Timothy P. Lynch serves as Executive at NABI BIOPHARMACEUTICALS, where they oversee executive responsibilities. Since joining the company, Timothy P. Lynch has executed 7 insider transactions totaling $20.0K, demonstrating a bearish approach to their equity position. Their most recent transaction on Feb 16, 2010 involved transacting 45,454 shares valued at $247.7K.
Timothy P. Lynch currently holds 240,000 shares of NABI BIOPHARMACEUTICALS (NABI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Timothy P. Lynch has been a net seller of NABI stock. They have purchased $0 and sold $20.0K worth of shares.
Timothy P. Lynch's most recent insider trade was on Feb 16, 2010, when they sold 45,454 shares at $5.45 per share.
Get notified when new Form 4 filings are submitted
| $5.20 |
| Discretionary |
| Jul 1, 2008 | ARDM | $192.0K | Other | 240,000 | $0.80 | Discretionary |
| Nov 9, 2007 | BFRM | $0 | Conversion | 45,454 | $N/A | Discretionary |
| Nov 9, 2007 | BFRM | $0 | Conversion | 45,454 | $N/A | Discretionary |
| Nov 9, 2007 | BFRM | $0 | Conversion | 45,454 | $N/A | Discretionary |
| May 18, 2007 | NABI | $20.0K | Award | 3,846 | $5.20 | Discretionary |